Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1600
-0.0050 (-3.13%)
Oct 31, 2025, 1:40 PM EDT
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 782.74K CAD in the quarter ending May 31, 2025, with 96.18% growth. This brings the company's revenue in the last twelve months to 2.47M, up 109.47% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.
Revenue (ttm)
2.47M
Revenue Growth
+109.47%
P/S Ratio
8.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
21.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 2.09M | 1.06M | 104.34% |
| Feb 29, 2024 | 1.02M | 302.13K | 42.06% |
| Feb 28, 2023 | 718.30K | -1.03M | -59.00% |
| Feb 28, 2022 | 1.75M | 996.72K | 131.98% |
| Feb 28, 2021 | 755.20K | 653.70K | 644.06% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| dentalcorp Holdings | 1.62B |
| Trulieve Cannabis | 1.62B |
| Green Thumb Industries | 1.57B |
| Extendicare | 1.51B |
| Verano Holdings | 1.16B |
| WELL Health Technologies | 1.12B |
| Sienna Senior Living | 929.68M |